Safe and efficacious use of recombinant human erythropoietin in malignancy.
Greaves
Paul
P
Department of Haematological Oncology, St Bartholomew's Hospital (Queen Mary, University of London), London. greaves.paul@gmail.com
Agrawal
Samir
S
D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin